The latest audit of PPP contracts in the health sector highlights a continuous increase in budget commitments and overruns of initial forecasts, putting increased pressure on public finances.
According to data made available by FSDKSH, the analysis of contracts shows discrepancies between the values ??foreseen in the standard documents, the real annual funding and the budget support planned in the 2023–2025 MTBP.
For the PPP contract "For the provision of integrated services for the supply of personalized sets of sterile surgical instruments, the supply of sterile single-use medical material in surgical rooms, the treatment of biologically hazardous waste and the disinfection of surgical rooms", the value foreseen in the standard documents, specifically in Annex 1, Chapter IV.1.1, is around 9.6 billion lek excluding VAT.
Referring to the progress of contract implementation and budget support planning, according to the MTBP 2023–2025, the budget support projections are exceeded.
Specifically, for 2022, 1.7 billion lek are foreseen from the annual budget and for 2023, 1.75 billion lek, while for 2024 and 2025, 1.77 billion lek and 1.79 billion lek are planned, respectively, which shows a clear trend of increasing financing for this contract.
Another problematic contract according to the audit is the PPP "Hemodialysis Service", for which the estimated value as budgetary support for a 10-year period amounts to 7.2 billion lek in total.
Actual financing costs have been increasing year by year. In 2021, invoices received amounted to around 750 million lek, in 2022 they increased to 807 million lek, while for 2023 the amount reached around 852 million lek. These figures are above the support initially foreseen in the contract, which for 2021 was 734 million lek, for 2022 786 million lek and for 2023 835 million lek. According to the audit, the method of liquidation of this contract had negative effects, as it led to the commitment of additional funds for budgetary support.
A significant increase is also evident in the PPP "Laboratory Service". The audit results show that the planned and actual expenditures for 2023, compared to 2022, mark an increase of about 136 million lek, or 111 million lek more.
This increase is not related to changes in reference prices, but to the performance of examinations with higher fees compared to those with lower fees, directly reflecting the increase in budgetary expenditures. The laboratory concession for 2023 has been financed with 6.9% additional funds compared to 2022.
Referring to data on expenditures incurred in the years 2020–2023, the respective amounts have increased from 1.1 billion lek to 1.7 billion lek, indicating that the laboratory concession continues to require continuous increases in funding, even in the face of restrictions on the provision of services to all patients or only for urgent tests.
The audit also finds that the review of the package content was carried out only for dialysis services and simple fistula and graft placement, by the technical committee, determining the visits, examinations, medical treatments and recalculating the relevant prices.
Meanwhile, for other packages, the costing continues to be determined by Council Decision No. 308, dated 21.5.2014, as amended by Council Decision No. 102, dated 5.2.2020, and since 2020, their content and prices have not been reviewed.
The audit recommendations emphasize that FSDKSH, in cooperation with the Ministry of Health and Social Protection, should take measures to establish working groups to review the content of all packages, including medical visits, examinations and treatments, as well as recalculate the relevant prices, in the context of continuous changes from 2020 to 2024.
Also, stronger monitoring of PPP contracts is required to track and discipline expenditures, using the effectiveness of funds, which are showing an increasing trend from year to year, not only as a result of the increase in cases, but also from the increase in the cost of service per patient./ ekofin.al